Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.
Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.
Displaying 625 questions Show Answers
To ask the Scottish Government what its position is on the (a) continuation of the Managed Alcohol Programme (MAP) in Scotland and (b) importance of MAP in addressing alcohol-related brain damage.
To ask the Scottish Government whether it will provide an update on its progress on reducing endometriosis diagnosis waiting times, and when it will publish data on this.
To ask the Scottish Government how it is supporting health and social care partnerships to implement the recommendations in the Mental Welfare Commission for Scotland 2021 report on care and treatment for people with alcohol-related brain damage.
To ask the Scottish Government whether it will develop a specific standard for the provision of alcohol-related brain damage services in every health and social care partnership.
To ask the Scottish Government what it has done to ensure that maternity wards and units are held to, and maintained at, an appropriate standard.
To ask the Scottish Government what it is doing to improve the experiences of women and girls when visiting their GP, in light of reports of some feeling dismissed or "gaslit" about their symptoms.
To ask the Scottish Government how it is actively reducing stigma by raising and normalising period awareness in all sporting environments.
To ask the Scottish Government what action it is taking to raise public awareness of alcohol-related brain damage.
To ask the Scottish Government what plans it has to support the roll-out of alcohol-related brain damage services across Scotland to ensure equal access to support and treatment for all patients.
To ask the Scottish Government whether patients with advanced or complex Parkinson’s disease have access to the most up-to-date therapies and services available.